Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Kinase cancers

BCR-ABL tyrosine kinase Cancer Point mutation causes resistance to STI-571 compound 21... [Pg.146]

Kleuser, B., Cuvillier, O., and Spiegel, S., 1998, la,25-dihydroxy vitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res. [Pg.281]

Zheng, F. F., S. D. Kuduk, G. Chiosis, P. N. Munster, L. Sepp-Lorenzino, S. J. Danishefsky, and N. Rosen. Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases. Cancer Res. 60 2090-4.2000a. [Pg.140]

Rabindran SK, Discafani CM, Rosljord EC et al. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Cancer Res 2004 64 3958-3965. [Pg.125]

Rodriguez, C.O., Jr. Mitchell, B.S. Ayres, M. Eriksson, S. Candhi, V. Ara-binosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase. Cancer Res., 62, 3100-3105 (2002)... [Pg.14]

She QB, Bode AM, Ma WY, Chen NY, Dong Z. 2001. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61 1604-1610. [Pg.328]

O. Wildner, R. M. Blaese, and J. C. Morris, Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase, Cancer Res. 59 410 (1999). [Pg.285]

Syljuasen RG, Jensen S, Bartek J, Lukas J. Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases. Cancer Res. 2006 66 10253-10257. [Pg.167]

Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, et al. 1997. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 57 4838 18... [Pg.221]

Hattori Y, Maitani Y (2005) Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther 12 796-809... [Pg.402]

Kurinna, S.M., Tsao, C.C., Nica, A.F., Jiffar, T., and Ruvolo, P.P. (2004). Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase. Cancer Res 64, 7852-6. [Pg.287]

Hirata, A., S. Ogawa, T. Kometani, T. Kuwano, S. Naito, M. Kuwano, and M. Ono. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res 62 2554-60, 2002. [Pg.144]

Mizuguchi H, Hayakawa T (2002). Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase. Cancer Gene Ther. 9 236-242. [Pg.1293]

Holmes-McNary M, Baldwin AS. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 2000 60 3477-3483. [Pg.251]

Yin, Z., Ivanov, V.N., Habelhah, H., Tew, K., and Ronai, Z., Glutathione S-transferase p elicits protection against H202-mduced cell death via coordinated regulation of stress kinases. Cancer Res., 60, 4053M057, 2000. [Pg.67]

Sunil KM, Nand KS, Robert AN et al (2000) Oleandrin suppresses activation of nuclear transcription factor-KB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res 60 3838-3847... [Pg.3756]

Kang HG, Jenabi JM, Zhang J. et al. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 2007 67 3094-105. [Pg.741]

Brockman RW, Cheng Y, Schabel FM Jr, Montgomery JA (1980) Metabolism and chemotherapeutic activity of 9-p-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase. Cancer Res 40 3610-3615... [Pg.757]

Bettayeb, K., Tirado, O.M., Marionneau-Lambot, S Eerandin, Y, Lozach, O., Morris, J.C., Mateo-Lozano, S., Drueckes, P Schachtele, C., Kubbutat, M.H.G., Liger, F., Marquet, B., Joseph, B Echalier, A., Endicott, J.A., Notario, V., and Meijer, L (2007) Meriolins, a new class of cell death-inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases. Cancer Res., 67, 8325-8334. [Pg.1698]


See other pages where Kinase cancers is mentioned: [Pg.53]    [Pg.263]    [Pg.266]    [Pg.100]    [Pg.94]    [Pg.263]    [Pg.2283]    [Pg.293]    [Pg.513]    [Pg.252]    [Pg.477]    [Pg.553]   
See also in sourсe #XX -- [ Pg.125 ]




SEARCH



Breast Cancer Human Epidermal Growth Factor Tyrosine Kinase Inhibitors

Breast cancer EGFR kinases

Breast cancer phosphatidylinositol-3-kinase

Cancer chemotherapy tyrosine kinase inhibitors

Cancer creatine kinase

Cancer cyclin-dependent protein kinases

Cancer, treatment using tyrosine kinase inhibitors

Cancer, treatment using tyrosine kinase receptor inhibitors

EphB4 Tyrosine Kinase (Cancer)

Kinase Mutations and Resistance in Cancer

Kinase cancer patients

Kinase cancer patients, therapeutic

Protein kinase inhibitors, for cancer

Tyrosine kinase inhibitors in cancer therapy

© 2024 chempedia.info